This Small Cap Stock Screams Opportunity!
We are taking profits on one stock and rolling that into a brand new small cap. Three weeks ago, we issued a buy recommendation on Eidos Therapeutics (EIDX) following heavy insider buying by the CEO and its parent company, BridgeBio Pharma. Despite massive sell offs in almost every sector, these insiders clearly knew something. It turns out…
